Last reviewed · How we verify
NCT04080336
Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women
Phase 4 trial testing Dinoprostone in IUD Insertion Complication in 129 participants. Completed in 20 January 2020.
20 December 2019
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 129 |
| Start date | 10 September 2019 |
| Primary completion | 20 December 2019 |
| Estimated completion | 20 January 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Dinoprostone (DINOPROSTONE) — full drug profile →
- Misoprostol (Misoprostol) — full drug profile →
- placebo
Conditions studied
- IUD Insertion Complication — all drugs for IUD Insertion Complication →
Sponsor
Cairo University
Who can join
18 and older, female only, with IUD Insertion Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the effect of vaginal dinoprostone versus vaginal misoprostol administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain and the difficulty in inserting the IUD in nulliparous women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04080336
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dinoprostone
Trials testing the same drug.
- NCT04597333 — Labor Induction After Failed Induction With Dinoprostone. · NA · completed
- NCT04079140 — Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion · Phase 4 · completed
- NCT04046302 — Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. · Phase 4 · completed
- NCT04044079 — Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients · Phase 4 · completed
- NCT04045548 — Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Pre · Phase 4 · completed
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04080336 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 30 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04080336.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing